CytoSorbents Awarded $2,897,172 Phase III STTR Contract to Advan

66
CTSO: CytoSorbents Corporation
2020-06-09 07:08:00
CytoSorbents Awarded $2,897,172 Phase III STTR Contract to Advance HemoDefend-BGA Plasma and Whole Blood Filter to Clinical Trials

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.